Overview

Sabril Patient Registry

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with Sabril and the prescribers of Sabril.
Details
Lead Sponsor:
Lundbeck LLC
Treatments:
Vigabatrin